Statement Of Financial Position [Abstract]

Alligator Bioscience - Filing #679585

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Right-of-use assets
17 613 SEK
25 550 SEK
Cash and cash equivalents
66 118 SEK
97 305 SEK
278 148 SEK
Assets
118 450 SEK
169 584 SEK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
42 170 SEK
88 614 SEK
Retained earnings
1 085 539 SEK
911 463 SEK
Equity attributable to owners of parent
11 855 SEK
89 051 SEK
Equity
42 170 SEK
1 085 539 SEK
1 055 224 SEK
11 855 SEK
89 051 SEK
911 463 SEK
88 614 SEK
911 901 SEK
282 273 SEK
717 792 SEK
911 831 SEK
88 234 SEK
Equity and liabilities
118 450 SEK
169 584 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.